Skip to content

ERODENT

Active
Private limited companyfounded 2023active for 3 yearsRue du Château 25, 4280 Hannut, BelgiumKBO/BCE: BE 0797.555.972

From the official registers: KBO 3 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

ERODENT has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €35,269 and a net result of €46,464. Equity has been stable since 2023 (±2% per year). Its solvency ranks better than 24% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 24-01-2023 Normal situation
Activity
Nutrition and dietetics services NACE 86995
Establishment units
5 establishment units
Financial year end
31 December
Peppol
Reachable since 28-10-2025

Board and ownership

Board

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Turnover
€129,178
Profit
€46,464
▲ 7.7%
Equity
€35,269
▼ 55.2%
Total assets
€125,290
▲ 40.3%
Filed on 13-03-2026, 140 days before the deadlinePDF
Score breakdownraises risk5 establishment unitslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.26, cash €99,661Figures for financial year 2025 (filed on 13-03-2026)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 39% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 53-47
equity 28.1% of total assets
Liquidity 61-38
short-term debt 71.9% · cash 79.5%
Profitability 100=
return on assets 37.1%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026highest value 06-2026: < 0.1%● unchanged vs 05-2026highest value 07-2026: < 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €3,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.26 (7.02 in 2024), below the usual 1.5. Short-term debt is 71.9% and cash 79.5% of total assets. 71.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 25% of them on solvency, 39% on liquidity, 80% on profitability and 11% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.26, cash €99,661
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 13-03-2026)
NBB · annual accounts
raises risk · 5 establishment units
KBO · seat and establishments
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 24%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-03-2026, 140 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
140 days early
2024
14 days early
2023
15 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 56 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 July (3 of the last 3 accounts filed within 126 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Comparable companies

These companies have the same main activity as ERODENT: nutrition and dietetics services (NACE 86995). They are comparable in size and age: total assets between €107,000 and €164,000, founded between 2021 and 2023.

CompanyTotal assetsGross margin
ERODENT Hannut€125,290€64,394
4BodyEvolution Villers-le-Bouillet€145,355€73,413
MEDIPART Herstal€153,613€60,369
BOUDRU SOPHIE PODOLOGUE Dalhem€164,262€56,199
Geneviève OFFERMANS Dalhem€109,635€70,411
Lilident Mechelen€159,308€60,120
RACHAD Charleroi€107,319€60,097
Full comparison

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about ERODENT

What is the company number of ERODENT?
The company number of ERODENT is 0797.555.972. The VAT number is the same number with BE in front: BE 0797.555.972.
Where is ERODENT based?
The registered office is at Rue du Château 25, 4280 Hannut.Company details
What does ERODENT do?
According to the KBO register, the main activity is nutrition and dietetics services (NACE 86995).
What is the legal form of ERODENT?
The legal form of ERODENT is Private limited company (BV).
When was ERODENT founded?
ERODENT was founded on 24-01-2023.
Is ERODENT still active?
Yes, ERODENT is an active enterprise in the KBO register.
What is the turnover of ERODENT?
The turnover of ERODENT was €129,178 in financial year 2025, according to the filed annual accounts.Financials
Is ERODENT profitable?
In financial year 2025, ERODENT made a profit of €46,464.
Where can I find the annual accounts of ERODENT?
ERODENT filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of ERODENT due?
ERODENT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.